{"abstract": "Eliquis is the third anticlotting medicine to be approved recently and it is expected the backers will aggressively market their products.", "web_url": "https://www.nytimes.com/2012/12/29/business/fda-approves-eliquis-from-bristol-and-pfizer.html", "snippet": "Eliquis is the third anticlotting medicine to be approved recently and it is expected the backers will aggressively market their products.", "lead_paragraph": "The Food and Drug Administration on Friday approved Eliquis, an anticlotting drug that has been highly anticipated by cardiologists and is expected to be a blockbuster for Bristol-Myers Squibb, which will make the drug, and Pfizer, which will help market it.", "print_section": "B", "print_page": "2", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2012/12/29/business/Blood/Blood-articleLarge.jpg", "height": 480, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2012/12/29/business/Blood/Blood-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 480}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2012/12/29/business/Blood/Blood-jumbo.jpg", "height": 819, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2012/12/29/business/Blood/Blood-superJumbo.jpg", "height": 1639, "width": 2048, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2012/12/29/business/Blood/Blood-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2012/12/29/business/Blood/Blood-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2012/12/29/business/Blood/Blood-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "F.D.A. Clears Anticlotting Drug by Bristol and Pfizer", "kicker": null, "content_kicker": null, "print_headline": "F.D.A. Clears Anticlotting Drug by Bristol and Pfizer", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Eliquis (Drug)", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Bristol Myers Squibb Company", "rank": 2, "major": "N"}, {"name": "subject", "value": "Blood Clots", "rank": 3, "major": "N"}, {"name": "subject", "value": "Blood", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Pfizer Inc", "rank": 5, "major": "N"}, {"name": "organizations", "value": "Food and Drug Administration", "rank": 6, "major": "N"}], "pub_date": "2012-12-29T01:59:57+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Katie Thomas", "person": [{"firstname": "Katie", "middlename": null, "lastname": "Thomas", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/f405252f-b263-5544-9e6c-f0e0cf46fa45", "word_count": 645, "uri": "nyt://article/f405252f-b263-5544-9e6c-f0e0cf46fa45"}